(AUPH) Aurinia Pharmaceuticals Renko charts technical analysis
(AUPH) Aurinia Pharmaceuticals Renko charts technical analysis Renko analysis of Aurinia Pharmaceuticals | Buy/Sell Aurinia Pharmaceuticals
Aurinia Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Aurinia Pharmaceuticals is 1200500
| Date | Closing Price | Open | High | Low | Volume |
| 04 Fri Apr 2025 | 7.81 | 7.81 | 7.98 | 7.72 | 1.567 Mn |
| 03 Thu Apr 2025 | 8.05 | 7.89 | 8.08 | 7.88 | 1.341 Mn |
| 02 Wed Apr 2025 | 8.19 | 7.95 | 8.20 | 7.93 | 1.432 Mn |
| 01 Tue Apr 2025 | 8.05 | 8.01 | 8.23 | 7.98 | 1.617 Mn |
| 31 Mon Mar 2025 | 8.04 | 8.20 | 8.23 | 7.93 | 1.475 Mn |
| 28 Fri Mar 2025 | 8.29 | 8.34 | 8.35 | 8.15 | 0.862 Mn |
| 24 Mon Mar 2025 | 8.53 | 8.52 | 8.60 | 8.49 | 0.843 Mn |
| 21 Fri Mar 2025 | 8.44 | 8.26 | 8.53 | 8.23 | 2.065 Mn |
| 20 Thu Mar 2025 | 8.32 | 8.30 | 8.46 | 8.28 | 0.699 Mn |
| 19 Wed Mar 2025 | 8.37 | 8.22 | 8.38 | 8.20 | 0.894 Mn |
Indicators analysis of Aurinia Pharmaceuticals (AUPH)
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term and the sell signal is strong.
Aurinia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.18 and Aurinia Pharmaceuticals (AUPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term and the sell signal is strong.
Aurinia Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.18 and Aurinia Pharmaceuticals (AUPH) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.